COVID-19 Impact on Global IV and Oral Iron Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 131 pages | ID: C6D10811ED0EEN
QYResearch

Abstracts

This report focuses on the global IV and Oral Iron Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IV and Oral Iron Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Daiichi Sankyo Company
• Vifor Pharma
• Akebia Therapeutics
• Allergan
• AMAG Pharmaceuticals
• AOP Orphan Pharmaceuticals
• Pharmacosmos
• Sanofi
• Shield Therapeutics
• AZAD Pharma
• Cirondrugs
• MEDICE
• Pfizer
• Salveo Lifecare
• Sunny Pharmaceutical

Market segment by Type, the product can be split into

• Oral Iron Drug
• IVIron Drugs

Market segment by Application, split into

• Nephrology
• OBGYN
• Surgeries
• Gastroenterology
• Oncology
• Heart failure (HF)

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global IV and Oral Iron Drugs status, future forecast, growth opportunity, key market and key players.
• To present the IV and Oral Iron Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of IV and Oral Iron Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by IV and Oral Iron Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Oral Iron Drug
  1.4.3 IVIron Drugs
1.5 Market by Application
  1.5.1 Global IV and Oral Iron Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Nephrology
  1.5.3 OBGYN
  1.5.4 Surgeries
  1.5.5 Gastroenterology
  1.5.6 Oncology
  1.5.7 Heart failure (HF)
1.6 Coronavirus Disease 2019 (Covid-19): IV and Oral Iron Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the IV and Oral Iron Drugs Industry
    1.6.1.1 IV and Oral Iron Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and IV and Oral Iron Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for IV and Oral Iron Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 IV and Oral Iron Drugs Market Perspective (2015-2026)
2.2 IV and Oral Iron Drugs Growth Trends by Regions
  2.2.1 IV and Oral Iron Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 IV and Oral Iron Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 IV and Oral Iron Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 IV and Oral Iron Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key IV and Oral Iron Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top IV and Oral Iron Drugs Players by Market Size
  3.1.1 Global Top IV and Oral Iron Drugs Players by Revenue (2015-2020)
  3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global IV and Oral Iron Drugs Market Concentration Ratio
  3.2.1 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by IV and Oral Iron Drugs Revenue in 2019
3.3 IV and Oral Iron Drugs Key Players Head office and Area Served
3.4 Key Players IV and Oral Iron Drugs Product Solution and Service
3.5 Date of Enter into IV and Oral Iron Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global IV and Oral Iron Drugs Historic Market Size by Type (2015-2020)
4.2 Global IV and Oral Iron Drugs Forecasted Market Size by Type (2021-2026)

5 IV AND ORAL IRON DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global IV and Oral Iron Drugs Market Size by Application (2015-2020)
5.2 Global IV and Oral Iron Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America IV and Oral Iron Drugs Market Size (2015-2020)
6.2 IV and Oral Iron Drugs Key Players in North America (2019-2020)
6.3 North America IV and Oral Iron Drugs Market Size by Type (2015-2020)
6.4 North America IV and Oral Iron Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe IV and Oral Iron Drugs Market Size (2015-2020)
7.2 IV and Oral Iron Drugs Key Players in Europe (2019-2020)
7.3 Europe IV and Oral Iron Drugs Market Size by Type (2015-2020)
7.4 Europe IV and Oral Iron Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China IV and Oral Iron Drugs Market Size (2015-2020)
8.2 IV and Oral Iron Drugs Key Players in China (2019-2020)
8.3 China IV and Oral Iron Drugs Market Size by Type (2015-2020)
8.4 China IV and Oral Iron Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan IV and Oral Iron Drugs Market Size (2015-2020)
9.2 IV and Oral Iron Drugs Key Players in Japan (2019-2020)
9.3 Japan IV and Oral Iron Drugs Market Size by Type (2015-2020)
9.4 Japan IV and Oral Iron Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia IV and Oral Iron Drugs Market Size (2015-2020)
10.2 IV and Oral Iron Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia IV and Oral Iron Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia IV and Oral Iron Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India IV and Oral Iron Drugs Market Size (2015-2020)
11.2 IV and Oral Iron Drugs Key Players in India (2019-2020)
11.3 India IV and Oral Iron Drugs Market Size by Type (2015-2020)
11.4 India IV and Oral Iron Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America IV and Oral Iron Drugs Market Size (2015-2020)
12.2 IV and Oral Iron Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America IV and Oral Iron Drugs Market Size by Type (2015-2020)
12.4 Central & South America IV and Oral Iron Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Daiichi Sankyo Company
  13.1.1 Daiichi Sankyo Company Company Details
  13.1.2 Daiichi Sankyo Company Business Overview and Its Total Revenue
  13.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Introduction
  13.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2015-2020))
  13.1.5 Daiichi Sankyo Company Recent Development
13.2 Vifor Pharma
  13.2.1 Vifor Pharma Company Details
  13.2.2 Vifor Pharma Business Overview and Its Total Revenue
  13.2.3 Vifor Pharma IV and Oral Iron Drugs Introduction
  13.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.2.5 Vifor Pharma Recent Development
13.3 Akebia Therapeutics
  13.3.1 Akebia Therapeutics Company Details
  13.3.2 Akebia Therapeutics Business Overview and Its Total Revenue
  13.3.3 Akebia Therapeutics IV and Oral Iron Drugs Introduction
  13.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.3.5 Akebia Therapeutics Recent Development
13.4 Allergan
  13.4.1 Allergan Company Details
  13.4.2 Allergan Business Overview and Its Total Revenue
  13.4.3 Allergan IV and Oral Iron Drugs Introduction
  13.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.4.5 Allergan Recent Development
13.5 AMAG Pharmaceuticals
  13.5.1 AMAG Pharmaceuticals Company Details
  13.5.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Introduction
  13.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.5.5 AMAG Pharmaceuticals Recent Development
13.6 AOP Orphan Pharmaceuticals
  13.6.1 AOP Orphan Pharmaceuticals Company Details
  13.6.2 AOP Orphan Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Introduction
  13.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.6.5 AOP Orphan Pharmaceuticals Recent Development
13.7 Pharmacosmos
  13.7.1 Pharmacosmos Company Details
  13.7.2 Pharmacosmos Business Overview and Its Total Revenue
  13.7.3 Pharmacosmos IV and Oral Iron Drugs Introduction
  13.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.7.5 Pharmacosmos Recent Development
13.8 Sanofi
  13.8.1 Sanofi Company Details
  13.8.2 Sanofi Business Overview and Its Total Revenue
  13.8.3 Sanofi IV and Oral Iron Drugs Introduction
  13.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.8.5 Sanofi Recent Development
13.9 Shield Therapeutics
  13.9.1 Shield Therapeutics Company Details
  13.9.2 Shield Therapeutics Business Overview and Its Total Revenue
  13.9.3 Shield Therapeutics IV and Oral Iron Drugs Introduction
  13.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.9.5 Shield Therapeutics Recent Development
13.10 AZAD Pharma
  13.10.1 AZAD Pharma Company Details
  13.10.2 AZAD Pharma Business Overview and Its Total Revenue
  13.10.3 AZAD Pharma IV and Oral Iron Drugs Introduction
  13.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2015-2020)
  13.10.5 AZAD Pharma Recent Development
13.11 Cirondrugs
  10.11.1 Cirondrugs Company Details
  10.11.2 Cirondrugs Business Overview and Its Total Revenue
  10.11.3 Cirondrugs IV and Oral Iron Drugs Introduction
  10.11.4 Cirondrugs Revenue in IV and Oral Iron Drugs Business (2015-2020)
  10.11.5 Cirondrugs Recent Development
13.12 MEDICE
  10.12.1 MEDICE Company Details
  10.12.2 MEDICE Business Overview and Its Total Revenue
  10.12.3 MEDICE IV and Oral Iron Drugs Introduction
  10.12.4 MEDICE Revenue in IV and Oral Iron Drugs Business (2015-2020)
  10.12.5 MEDICE Recent Development
13.13 Pfizer
  10.13.1 Pfizer Company Details
  10.13.2 Pfizer Business Overview and Its Total Revenue
  10.13.3 Pfizer IV and Oral Iron Drugs Introduction
  10.13.4 Pfizer Revenue in IV and Oral Iron Drugs Business (2015-2020)
  10.13.5 Pfizer Recent Development
13.14 Salveo Lifecare
  10.14.1 Salveo Lifecare Company Details
  10.14.2 Salveo Lifecare Business Overview and Its Total Revenue
  10.14.3 Salveo Lifecare IV and Oral Iron Drugs Introduction
  10.14.4 Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2015-2020)
  10.14.5 Salveo Lifecare Recent Development
13.15 Sunny Pharmaceutical
  10.15.1 Sunny Pharmaceutical Company Details
  10.15.2 Sunny Pharmaceutical Business Overview and Its Total Revenue
  10.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Introduction
  10.15.4 Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2015-2020)
  10.15.5 Sunny Pharmaceutical Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. IV and Oral Iron Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by IV and Oral Iron Drugs Revenue
Table 3. Ranking of Global Top IV and Oral Iron Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global IV and Oral Iron Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Iron Drug
Table 6. Key Players of IVIron Drugs
Table 7. COVID-19 Impact Global Market: (Four IV and Oral Iron Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for IV and Oral Iron Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for IV and Oral Iron Drugs Players to Combat Covid-19 Impact
Table 12. Global IV and Oral Iron Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global IV and Oral Iron Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global IV and Oral Iron Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global IV and Oral Iron Drugs Market Share by Regions (2015-2020)
Table 16. Global IV and Oral Iron Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global IV and Oral Iron Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. IV and Oral Iron Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key IV and Oral Iron Drugs Players
Table 23. Global IV and Oral Iron Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global IV and Oral Iron Drugs Market Share by Players (2015-2020)
Table 25. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IV and Oral Iron Drugs as of 2019)
Table 26. Global IV and Oral Iron Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players IV and Oral Iron Drugs Product Solution and Service
Table 29. Date of Enter into IV and Oral Iron Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global IV and Oral Iron Drugs Market Size Share by Type (2015-2020)
Table 33. Global IV and Oral Iron Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global IV and Oral Iron Drugs Market Size Share by Application (2015-2020)
Table 35. Global IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global IV and Oral Iron Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 39. North America IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 41. North America IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 45. Europe IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 47. Europe IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 49. China Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 51. China IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 53. China IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 57. Japan IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 59. Japan IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 63. Southeast Asia IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 67. India Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 69. India IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 71. India IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players IV and Oral Iron Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players IV and Oral Iron Drugs Market Share (2019-2020)
Table 75. Central & South America IV and Oral Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America IV and Oral Iron Drugs Market Share by Type (2015-2020)
Table 77. Central & South America IV and Oral Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America IV and Oral Iron Drugs Market Share by Application (2015-2020)
Table 79. Daiichi Sankyo Company Company Details
Table 80. Daiichi Sankyo Company Business Overview
Table 81. Daiichi Sankyo Company Product
Table 82. Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 83. Daiichi Sankyo Company Recent Development
Table 84. Vifor Pharma Company Details
Table 85. Vifor Pharma Business Overview
Table 86. Vifor Pharma Product
Table 87. Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 88. Vifor Pharma Recent Development
Table 89. Akebia Therapeutics Company Details
Table 90. Akebia Therapeutics Business Overview
Table 91. Akebia Therapeutics Product
Table 92. Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 93. Akebia Therapeutics Recent Development
Table 94. Allergan Company Details
Table 95. Allergan Business Overview
Table 96. Allergan Product
Table 97. Allergan Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 98. Allergan Recent Development
Table 99. AMAG Pharmaceuticals Company Details
Table 100. AMAG Pharmaceuticals Business Overview
Table 101. AMAG Pharmaceuticals Product
Table 102. AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 103. AMAG Pharmaceuticals Recent Development
Table 104. AOP Orphan Pharmaceuticals Company Details
Table 105. AOP Orphan Pharmaceuticals Business Overview
Table 106. AOP Orphan Pharmaceuticals Product
Table 107. AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 108. AOP Orphan Pharmaceuticals Recent Development
Table 109. Pharmacosmos Company Details
Table 110. Pharmacosmos Business Overview
Table 111. Pharmacosmos Product
Table 112. Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 113. Pharmacosmos Recent Development
Table 114. Sanofi Business Overview
Table 115. Sanofi Product
Table 116. Sanofi Company Details
Table 117. Sanofi Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 118. Sanofi Recent Development
Table 119. Shield Therapeutics Company Details
Table 120. Shield Therapeutics Business Overview
Table 121. Shield Therapeutics Product
Table 122. Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 123. Shield Therapeutics Recent Development
Table 124. AZAD Pharma Company Details
Table 125. AZAD Pharma Business Overview
Table 126. AZAD Pharma Product
Table 127. AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 128. AZAD Pharma Recent Development
Table 129. Cirondrugs Company Details
Table 130. Cirondrugs Business Overview
Table 131. Cirondrugs Product
Table 132. Cirondrugs Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 133. Cirondrugs Recent Development
Table 134. MEDICE Company Details
Table 135. MEDICE Business Overview
Table 136. MEDICE Product
Table 137. MEDICE Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 138. MEDICE Recent Development
Table 139. Pfizer Company Details
Table 140. Pfizer Business Overview
Table 141. Pfizer Product
Table 142. Pfizer Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 143. Pfizer Recent Development
Table 144. Salveo Lifecare Company Details
Table 145. Salveo Lifecare Business Overview
Table 146. Salveo Lifecare Product
Table 147. Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 148. Salveo Lifecare Recent Development
Table 149. Sunny Pharmaceutical Company Details
Table 150. Sunny Pharmaceutical Business Overview
Table 151. Sunny Pharmaceutical Product
Table 152. Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2015-2020) (Million US$)
Table 153. Sunny Pharmaceutical Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global IV and Oral Iron Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Iron Drug Features
Figure 3. IVIron Drugs Features
Figure 4. Global IV and Oral Iron Drugs Market Share by Application: 2020 VS 2026
Figure 5. Nephrology Case Studies
Figure 6. OBGYN Case Studies
Figure 7. Surgeries Case Studies
Figure 8. Gastroenterology Case Studies
Figure 9. Oncology Case Studies
Figure 10. Heart failure (HF) Case Studies
Figure 11. IV and Oral Iron Drugs Report Years Considered
Figure 12. Global IV and Oral Iron Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global IV and Oral Iron Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global IV and Oral Iron Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global IV and Oral Iron Drugs Market Share by Players in 2019
Figure 17. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IV and Oral Iron Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by IV and Oral Iron Drugs Revenue in 2019
Figure 19. North America IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America IV and Oral Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Daiichi Sankyo Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Daiichi Sankyo Company Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 28. Vifor Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Vifor Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 30. Akebia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Akebia Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 32. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Allergan Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 34. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. AMAG Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 36. AOP Orphan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AOP Orphan Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 38. Pharmacosmos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pharmacosmos Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 42. Shield Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Shield Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 44. AZAD Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. AZAD Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 46. Cirondrugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Cirondrugs Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 48. MEDICE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. MEDICE Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 52. Salveo Lifecare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Salveo Lifecare Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 54. Sunny Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sunny Pharmaceutical Revenue Growth Rate in IV and Oral Iron Drugs Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed